Evidence map›Paper›PMID 21078684›Full record

Trial reportEuropean journal of endocrinology2011

Beta cell function after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention.

D Hofsø, T Jenssen, J Bollerslev, T Ueland, K Godang, M Stumvoll, R Sandbu, J Røislien, J Hjelmesæth

Registry-linked trialOpen access · bronzeAbstract readClinical TrialComparative Study
In one paragraph

Trial report in European journal of endocrinology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00273104 (The Effect of Lifestyle Intervention vs Gastric Bypass on Various Comorbidities), which is not on this map. Cited by 34 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 8 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00273104 nacompletednot on this map

The Effect of Lifestyle Intervention vs Gastric Bypass on Various Comorbidities

TypeinterventionalSponsorThe Hospital of VestfoldRan2005 to 2017Enrolled180ConditionsObstructive Sleep Apnea, Diabetes Mellitus, HypertensionArmsBariatric surgery, Intensive lifestyle intervention
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 8 syntheses or guidelines pooled it, 83 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. European Guidelines for Obesity Management in Adults.Obesity facts · 2015 · on this map
    Guideline
  4. Surgery for weight loss in adults.The Cochrane database of systematic reviews · 2014
    Pooled it
  5. Guideline
  6. Guideline
  7. Guideline
  8. Guideline
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

D HofsøDepartment of Medicine, Morbid Obesity Centre, Vestfold Hospital Trust, Tønsberg, Norway. dag.hofso@siv.no
T Jenssen
J Bollerslev
T Ueland
K Godang
M Stumvoll
R Sandbu
J Røislien
J Hjelmesæth
Sykehuset i Vestfold · NOOslo University Hospital · NOUniversity of Oslo · NOLeipzig University of Applied Sciences · DEUiT The Arctic University of Norway · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe effects of various weight loss strategies on pancreatic beta cell function remain unclear. We aimed to compare the effect of intensive lifestyle intervention (ILI) and Roux-en-Y gastric bypass surgery (RYGB) on beta cell function.

designOne year controlled clinical trial (ClinicalTrials.gov identifier NCT00273104).

methodsOne hundred and nineteen morbidly obese participants without known diabetes from the MOBIL study (mean (s.d.) age 43.6 (10.8) years, body mass index (BMI) 45.5 (5.6) kg/m², 84 women) were allocated to RYGB (n = 64) or ILI (n = 55). The patients underwent repeated oral glucose tolerance tests (OGTTs) and were categorised as having either normal (NGT) or abnormal glucose tolerance (AGT). Twenty-nine normal-weight subjects with NGT (age 42.6 (8.7) years, BMI 22.6 (1.5) kg/m², 19 women) served as controls. OGTT-based indices of beta cell function were calculated.

resultsOne year weight reduction was 30% (8) after RYGB and 9% (10) after ILI (P < 0.001). Disposition index (DI) increased in all treatment groups (all P<0.05), although more in the surgery groups (both P < 0.001). Stimulated proinsulin-to-insulin (PI/I) ratio decreased in both surgery groups (both P < 0.001), but to a greater extent in the surgery group with AGT at baseline (P < 0.001). Post surgery, patients with NGT at baseline had higher DI and lower stimulated PI/I ratio than controls (both P < 0.027).

conclusionsGastric bypass surgery improved beta cell function to a significantly greater extent than ILI. Supra-physiological insulin secretion and proinsulin processing may indicate excessive beta cell function after gastric bypass surgery.

Indexed as

Gastric BypassAdultAnalysis of VarianceBody Mass IndexChromatography, High Pressure LiquidDiet, ReducingExercise TherapyFemaleGlucose Tolerance TestGlycated HemoglobinHumansInsulinInsulin ResistanceInsulin-Secreting CellsLife StyleMaleGlycated HemoglobinInsulin

Identifiers

PMID21078684
PMCPMC3022337
OpenAlexW2123772228

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.